Financials

Discussions Technicals Seasonals

6945 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

AP Biosciences, Inc. engages in the research and development of new antibody drug and immunotherapy drugs. It focuses on the cancer immunotherapy bi-specific antibody drugs. The company was founded on May 27, 2013 and is headquartered in Taipei, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

6945 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company